Editorial Board for section 'Cancer Immunology and Immunotherapy'
- Molecular Cancer Biology Section
- Cancer Immunology and Immunotherapy Section
- Cancer Biomarkers Section
- Cancer Epidemiology and Prevention Section
- Cancer Pathophysiology Section
- Tumor Microenvironment Section
- Cancer Causes, Screening and Diagnosis Section
- Cancer Survivorship and Quality of Life Section
- Cancer Therapy Section
- Clinical Research of Cancer Section
- Systematic Review or Meta-Analysis in Cancer Research Section
- Methods and Technologies Development Section
- Cancer Informatics and Big Data Section
- Pediatric Oncology Section
- Infectious Agents and Cancer Section
- Cancer Drug Development Section
- Cancer Metastasis Section
- Transplant Oncology Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Vall d’Hebrón Institute of Oncology (VHIO), International Breast Cancer Center, Quiron Group, 08035 Barcelona, Spain
Interests: Breast cancer; Anti HER2 therapy; immunotherapy; triple negative breast cancer
Interests: Breast cancer; Anti HER2 therapy; immunotherapy; triple negative breast cancer
Azienda ospedaliero-universitaria Policlinico S.Orsola-Malpighi, Department of Hematology and Oncology, Institute of Hematology “L. and A. Seràgnoli”, Via Massarenti 9, 40138 Bologna, Italy
Interests: acute leukemias; immunotherapy; tolerance; NK cells; clinical trials
Special Issues, Collections and Topics in MDPI journals
Interests: acute leukemias; immunotherapy; tolerance; NK cells; clinical trials
Special Issues, Collections and Topics in MDPI journals
Department of Pathology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
Interests: cancer genomics; cancer immunology; immunotherapy; immunogenomics; colorectal cancer; pancreatic cancer; TGF-beta
Interests: cancer genomics; cancer immunology; immunotherapy; immunogenomics; colorectal cancer; pancreatic cancer; TGF-beta
Department of Medical Oncology, University Hospital 12 de Octubre, 28041 Madrid, Spain
Interests: renal cell carcinoma; bladder cancer; biomarkers; clinical trials
Interests: renal cell carcinoma; bladder cancer; biomarkers; clinical trials
Laboratory of Molecular Immunology and Signal Transduction, GIGA-Institute, University of Liege, 4000 Liege, Belgium
Interests: immune signaling; lymphioma; liver cancer; NFkB; cell death; TNF; lymphotoxin; innate immune response
Interests: immune signaling; lymphioma; liver cancer; NFkB; cell death; TNF; lymphotoxin; innate immune response
Medical Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, CEDEX 09, 31059 Toulouse, France
Interests: first in Human trials; Head and Neck Cancer; PK-PD studies; microenvironement
Interests: first in Human trials; Head and Neck Cancer; PK-PD studies; microenvironement
Molecular Genetics Laboratory, Department of Oral Biology, Faculty of Dentistry, University of Oslo, 0316 Oslo, Norway
Interests: T-cell development; risk for developing cancer; IFN-gamma signaling; T-cell receptor biology; risk for developing osteoarthritis
Interests: T-cell development; risk for developing cancer; IFN-gamma signaling; T-cell receptor biology; risk for developing osteoarthritis
Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia
Interests: cancer immunotherapy; tumour (neo-)antigen validation; cancer vaccines; immunomonitoring; clinical trials
Special Issues, Collections and Topics in MDPI journals
Interests: cancer immunotherapy; tumour (neo-)antigen validation; cancer vaccines; immunomonitoring; clinical trials
Special Issues, Collections and Topics in MDPI journals
National Center for Cancer Immuno Therapy, CCIT-DK, Department of Oncology, Copenhagen University Hospital, 2730 Herlev, Denmark
Interests: Cancer Immunotherapy; T cell therapy; Melanoma
Interests: Cancer Immunotherapy; T cell therapy; Melanoma
Department of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland
Interests: skin cancer immunology; immunotherapy; targeted therapy; melanoma; non-melanoma skin cancer; cutaneous lymphoma
Special Issues, Collections and Topics in MDPI journals
Interests: skin cancer immunology; immunotherapy; targeted therapy; melanoma; non-melanoma skin cancer; cutaneous lymphoma
Special Issues, Collections and Topics in MDPI journals
Director of the Tumor Biotherapy Unit, Experimental Oncology Department, European Institute of Oncology, Milano, Italy
Interests: melanoma; skin cancer; Immunotherapy; targeted therapy
Interests: melanoma; skin cancer; Immunotherapy; targeted therapy
1. Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, USA
2. Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA
Interests: nanoparticles; cancer; immunology
Special Issues, Collections and Topics in MDPI journals
2. Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA
Interests: nanoparticles; cancer; immunology
Special Issues, Collections and Topics in MDPI journals
Department of Bioengineering and James Graham Brown Cancer Center, University of Louisville, Lutz Hall 419, Louisville, KY 40292, USA
Interests: Mathematical modeling; computational simulation; nanotherapy; immune therapy
Interests: Mathematical modeling; computational simulation; nanotherapy; immune therapy
Mater Research Institute, The University of Queensland, Brisbane, QLD 4102, Australia
Interests: Melanoma; cell cycle; DNA damage response; UV radiation; targeted therapy; Cell cycle inhibitors; HPV; cervical cancer
Interests: Melanoma; cell cycle; DNA damage response; UV radiation; targeted therapy; Cell cycle inhibitors; HPV; cervical cancer
Department of Translational Medicine, University of Eastern, 28100 Novara, Italy
Interests: papillomavirus; virus-associated cancer; innate immunity; IFI16; interferon
Interests: papillomavirus; virus-associated cancer; innate immunity; IFI16; interferon
Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, 10126 Torino, Italy
Interests: myeloma; plasma cell discrasia; autologous stem cell transplant; immunotherapies
Special Issues, Collections and Topics in MDPI journals
Interests: myeloma; plasma cell discrasia; autologous stem cell transplant; immunotherapies
Special Issues, Collections and Topics in MDPI journals
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada
Interests: cytokines; immunotherapy; tumour-associated macrophages; JAK-STAT signaling
Interests: cytokines; immunotherapy; tumour-associated macrophages; JAK-STAT signaling
Department of Medical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
Interests: prostate cancer; cancer immunology and immunotherapy
Interests: prostate cancer; cancer immunology and immunotherapy
Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, TN 37232-0252, USA
Interests: gastrointestinal inflammation; gastric cancer; colitis-associated carcinogenesis; colorectal cancer; polyamines; reactive aldehydes
Special Issues, Collections and Topics in MDPI journals
Interests: gastrointestinal inflammation; gastric cancer; colitis-associated carcinogenesis; colorectal cancer; polyamines; reactive aldehydes
Special Issues, Collections and Topics in MDPI journals
1. Department of Functional Biology, Immunology, Universidad de Oviedo, 33006 Oviedo, Spain
2. Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Spain
3. Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain
Interests: Immunology; NK cells; T cells; cancer; immunotherapy
Interests: Immunology; NK cells; T cells; cancer; immunotherapy
1. Associate Professor, Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy
2. Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy
Interests: hepatocellular carcinoma; liver cancer; autoimmune hepatitis; primary biliary cholangitis; primary sclerosing cholangitis; celiac disease
Special Issues, Collections and Topics in MDPI journals
2. Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy
Interests: hepatocellular carcinoma; liver cancer; autoimmune hepatitis; primary biliary cholangitis; primary sclerosing cholangitis; celiac disease
Special Issues, Collections and Topics in MDPI journals
1. Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD), Im Neuenheimer Feld 460, 69120 Heidelberg, Germany
2. Division of Translational Immunotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Interests: tumor immunology; biomarker identification; solid tumors
2. Division of Translational Immunotherapy, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Interests: tumor immunology; biomarker identification; solid tumors
Laboratory of Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1, Inohana, Chuou-ku, Chiba 260-0856, Japan
Interests: pharmaceutics; drug delivery system; immune checkpoint inhibitors; lipid nanoparticles; liposomes; antibody drug; cancer immunotherapy; cancer biology; thermal biology
Interests: pharmaceutics; drug delivery system; immune checkpoint inhibitors; lipid nanoparticles; liposomes; antibody drug; cancer immunotherapy; cancer biology; thermal biology
1. Melanoma Immunology and Oncology Program, The Centenary Institute, University of Sydney, Camperdown 2050, Australia
2. Melanoma Institute Australia, Crows Nest, Sydney 2065, Australia
Interests: melanoma; skin cancer; immune therapies
2. Melanoma Institute Australia, Crows Nest, Sydney 2065, Australia
Interests: melanoma; skin cancer; immune therapies
Lung Cancer Network NOWEL, 26129 Oldenburg, Germany
Interests: liquid biopsy; TP53; biomarker; NSCLC; immunotherapy
Interests: liquid biopsy; TP53; biomarker; NSCLC; immunotherapy
Department of Hepatology & Gastroenterology, Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, 13353 Berlin, Germany
Interests: acute and chronic inflammation; macrophages; macrophage ontogeny; innate immunity; intravital imaging; T cells and T cell priming; wound healing; fibrosis; hepatocarcinogenesis; hepatic macrophages; hepatic Inflammation
Special Issues, Collections and Topics in MDPI journals
Interests: acute and chronic inflammation; macrophages; macrophage ontogeny; innate immunity; intravital imaging; T cells and T cell priming; wound healing; fibrosis; hepatocarcinogenesis; hepatic macrophages; hepatic Inflammation
Special Issues, Collections and Topics in MDPI journals
Department of Dermatology, University of Zürich, Zürich, Switzerland
Interests: squamous cell carcinoma of the skin
Interests: squamous cell carcinoma of the skin
Institut Cochin, CNRS, INSERM, F-75014 Paris, France
Interests: hiv; cells
Interests: hiv; cells
Cancer Immunology Laboratory, Monash University, Clayton, VIC 3800, Australia
Interests: drug discovery; screening; innate immunity; cancer immunotherapy
Special Issues, Collections and Topics in MDPI journals
Interests: drug discovery; screening; innate immunity; cancer immunotherapy
Special Issues, Collections and Topics in MDPI journals
Hematology with Bone Marrow Transplantation Unit, Department of Oncology, “La Maddalena” San Lorenzo Street 312/d, 90146 Palermo, Italy
Interests: hodgkin lymphoma; SMZL; MCL; non-hodgkin lymphoma; CLL
Interests: hodgkin lymphoma; SMZL; MCL; non-hodgkin lymphoma; CLL
